Cronos Group Inc (NASDAQ:CRON) is one of the best CBD stocks to buy right now. The stock is up roughly 40% over the past year ...

Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Cronos Group (NASDAQ: CRON) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 earnings this morning. Heading into the report, analysts expected Cronos to do ...

For its second quarter, Cronos -- which reports in U.S. dollars -- took in nearly $27.8 million in revenue, a figure almost 50% higher than the $19 million it earned in the same period of 2023. On a ...

For years, North American cannabis investors have endured a brutal hangover. Cronos Group (NASDAQ:CRON), once a darling of the 2018-2019 marijuana mania, watched its share price collapse more than 95% ...

View Cronos Group Inc CRON stock quote prices, financial information, real-time forecasts, and company news from CNN.

TORONTO, March 16, 2026 (GLOBE NEWSWIRE)-- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, ...

The average one-year price target for Cronos Group (NasdaqGM:CRON) has been revised to $3.79 / share. This is an increase of ...

Detailed price information for Cronos Group Inc (CRON-Q) from The Globe and Mail including charting and trades.